Position in NVS
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$2,721,129
+$68,931 QoQ
Shares Held
17,363
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#365
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EVERETT HARRIS & CO /CA/ holds $616,457,307 across 12 Drug Manufacturers - General names. NVS ranks #8 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVO |
Novo Nordisk A S
|
6,475,622 | $310,441,318 | |
| 2 | ABBV |
AbbVie Inc.
|
512,541 | $128,975,817 | |
| 3 | JNJ |
Johnson & Johnson
|
469,392 | $119,211,486 | |
| 4 | MRK |
Merck & Co., Inc.
|
221,036 | $28,403,126 | |
| 5 | LLY |
ELI LILLY & Co
|
8,557 | $10,263,523 | |
| 6 | AMGN |
Amgen Inc
|
23,296 | $8,435,947 | |
| 7 | PFE |
Pfizer Inc
|
283,402 | $6,824,320 | |
| 8 | NVS |
Novartis AG
This page
|
17,363 | $2,721,129 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,721,129 | 17,363 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $2,652,198 | 17,363 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $2,669,576 | 19,363 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $2,483,111 | 19,363 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $2,343,116 | 19,363 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,320,233 | 20,813 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $2,048,180 | 21,048 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $2,464,073 | 21,423 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $2,288,144 | 21,493 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $2,079,017 | 21,493 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $2,229,720 | 22,083 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $2,904,945 | 28,519 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $3,019,126 | 29,919 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $2,881,348 | 31,319 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $2,927,443 | 32,269 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $3,963,085 | 52,139 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $5,479,403 | 64,822 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $6,322,475 | 72,051 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $8,953,254 | 102,358 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $19,056,620 | 233,023 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $27,016,893 | 296,108 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $24,972,640 | 292,146 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $23,874,736 | 252,830 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $7,178,026 | 82,544 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $2,097,994 | 24,021 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $1,558,140 | 18,898 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||